These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23263849)

  • 1. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.
    Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z
    Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.
    Amirghofran Z; Asiaee E; Kamazani FM
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis.
    Vaskova M; Fronkova E; Starkova J; Kalina T; Mejstrikova E; Hrusak O
    Tissue Antigens; 2008 Jan; 71(1):57-66. PubMed ID: 18005092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia.
    Chen D; Gerasimčik N; Camponeschi A; Tan Y; Wu Q; Brynjolfsson S; Zheng J; Abrahamsson J; Nordlund J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Blood Cancer J; 2017 Jun; 7(6):e575. PubMed ID: 28649984
    [No Abstract]   [Full Text] [Related]  

  • 5. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
    Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
    Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
    Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
    Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
    Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Meisel R; Hanenberg H; den Boer ML; Pieters R; Janka-Schaub GE; Goebel U; Laws HJ; Dilloo D
    Blood; 2008 Aug; 112(4):1028-34. PubMed ID: 18552209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
    De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
    Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic significance of CD27 and CD44 expression patterns in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.
    Abobakr A; Osman RA; Kamal MAM; Abdelhameed SA; Ismail HH; Kamel MM; Alsharif KF; Hamad NR
    Hematol Transfus Cell Ther; 2023 Dec; ():. PubMed ID: 38065726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.
    Alessandri AJ; Reid GS; Bader SA; Massing BG; Sorensen PH; Schultz KR
    Br J Haematol; 2002 Feb; 116(2):266-72. PubMed ID: 11841426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
    Al-Sweedan SA; Neglia JP; Steiner ME; Bostrom BC; Casey T; Hirsch BA
    Pediatr Blood Cancer; 2007 May; 48(5):510-4. PubMed ID: 16763978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
    Khan NI; Cisterne A; Devidas M; Shuster J; Hunger SP; Shaw PJ; Bradstock KF; Bendall LJ
    Leuk Lymphoma; 2008 Apr; 49(4):710-8. PubMed ID: 18398738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
    Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.
    Dai Q; Liu X; Yang H; Guo S; Wang Y; Peng L; Ye L; Chen L; Lai C; Chen Q; Zhang G; Jiang Y
    Leuk Res; 2018 May; 68():57-61. PubMed ID: 29544133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
    Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F
    Blood; 1997 Dec; 90(12):4933-7. PubMed ID: 9389711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
    Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
    Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.